Supportive Care | Specialty

Advances in Immuno-Oncology

June 17th 2015

ImmunoScore: Predictive and Prognostic?

June 17th 2015

Society for Immunotherapy in Cancer

June 17th 2015

Olanzapine Shown to Control CINV in Patients With Esophageal, Head and Neck Cancer

June 15th 2015

Olanzapine (Zyprexa) demonstrated an improvement in antinausea effects in patients receiving concurrent highly emetogenic chemotherapy and radiation therapy for advanced stage head and neck and esophageal cancer when compared to fosaprepitant.

Melinda Irwin on Impact of Exercise on Survivors' Quality of Life

June 15th 2015

Melinda Liggett Irwin, PhD, MPH, associate professor of epidemiology (chronic diseases), Yale School of Public Health, co-program leader, Cancer Prevention and Control Research Program, Yale Cancer Center, discusses the impact of the LIVESTRONG at the YMCA Program on survivors' fitness, physical activity, and quality of life.

Exercise Linked to Reduction in Chemotherapy-Induced Cognitive Impairment

June 15th 2015

Risk of inflammation and cognitive impairment due to chemotherapy, often called "chemobrain", may be reduced by maintaining physical activity during treatment.

Preventing and Managing Regorafenib-Related Hand-Foot Skin Reaction

June 14th 2015

Many oncology professionals who treat patients on regorafenib are unfamiliar with how to manage and prevent hand-foot skin reaction.

Pembrolizumab Priority Review, Benefits of Early Palliative Care, and More

June 13th 2015

Dr. Jerome Kim on Geriatric Assessment Tool for Older Patients With Cancer

June 9th 2015

Jerome G. Kim, MD, medical oncologist, hematologist, Kaiser Permanente, discusses the feasibility of an assessment tool for older adults with cancer using web-based platforms.

Survivorship and Chronic Pain Management for Cancer Pain

May 24th 2015

The rise in survivorship has increased chronic pain in the cancer pain population, the treatment of which has many fundamental differences when compared to acute and terminal cancer pain.

Expanding Use of Oral Therapies Puts Challenges of Patient Compliance in Spotlight

May 22nd 2015

Dr. Maurie Markman discusses how the transition to the new therapeutic paradigm of oral therapies necessitates that we consider unique aspects of this strategy that may negatively impact outcomes compared with an approach of systemic antineoplastic drug administration.

Impairment-Driven Cancer Rehabilitation Improves Survivors' Quality of Life

May 22nd 2015

The lack of comprehensive rehabilitation services is a profound source of unnecessary suffering for survivors.

Sexual Function Scores Are Better After Robotic Versus Open Surgery for Prostate Cancer

May 18th 2015

Sexual function scores were better for patients who had a robotic compared with open surgery for prostate cancer; however, comparative results for urinary function were not conclusive.

Siteman Cancer Center Houses Broad Research Program

May 15th 2015

Venetoclax Breakthrough Designation, Zarxio Legal Update, and More

May 15th 2015

Dr. Sanft on How Survivorship Care Plans Differ Among Patients

May 12th 2015

Tara Sanft, MD, assistant professor of medicine, director, Survivorship Clinic, Smilow Cancer Hospital at Yale-New Haven, discusses survivorship care plans and how they can differ among patients.

First FDA-Approved Biosimilar Blocked From Entering US Market

May 8th 2015

The first FDA-approved biosimilar, Zarxio, has been blocked from reaching US markets by an injunction from Amgen, the manufacturer of the G-CSF analog counterpart, Neupogen (filgrastim).

Eltrombopag Effectively Treats Cytopenias in MDS

May 2nd 2015

Treatment with the thrombopoietin receptor agonist eltrombopag significantly improved cytopenias and was well-tolerated in patients with low to intermediate-2 risk myelodysplastic syndromes.

Supportive Care Remains Backbone of Treatment in MDS

May 1st 2015

Treatment strategies for patients with myelodysplastic syndromes are built upon a foundation of supportive care, which consists of transfusions, iron chelation, and growth factor therapy.

Dr. Kapo on Addressing Palliative Care With Patients

April 29th 2015

Jennifer M. Kapo, MD, chief, palliative medicine, Yale Cancer Center, associate professor of medicine (medical oncology and geriatrics), Yale School of Medicine, discusses how oncologists can address palliative care with their patients.